Protagonist Therapeutics, Inc. (PTGX)

Protagonist Therapeutics experienced significant insider selling activity recently, totaling over $66 million in value. CEO Dinesh Patel executed multiple divestments following the company's August earnings report, which showed an 8.5% EPS beat. These transactions occurred while the stock price traded near its 52-week high, reflecting a period of notable equity liquidation by leadership.
Ticker: PTGX Exchange: NMS


Loading...
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Protagonist Therapeutics, Inc.. Upgrade to see score, net flow, insiders and the full signal context.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.4
PATEL DINESH V PH D President and CEO Executive Director
Transaction date
Sale
Price
104.74
Quantity 34,410 -41.5%
Value US$2,070,241
2.4
PATEL DINESH V PH D President and CEO Executive Director
Transaction date
Sale
Price
332.06
Quantity 39,963 -3.3%
Value US$2,305,480
2.4
PATEL DINESH V PH D President and CEO Executive Director
Transaction date
Sale
Price
420.97
Quantity 92,506 -27.0%
Value US$1,136,455
2.4
PATEL DINESH V PH D President and CEO Executive Director
Transaction date
Sale
Price
148.52
Quantity 34,239 -6.1%
Value US$5,085,176
2.4
PATEL DINESH V PH D President and CEO Executive Director
Transaction date
Sale
Price
149.11
Quantity 65,761 -11.2%
Value US$9,805,623
2.4
Dinesh Patel CEO
Transaction date
Proposed sale
Price
149.26
Quantity 225,000
Value US$33,583,500
2.1
Waddill William D. Non-Executive Director
Transaction date
Sale
Price
117.94
Quantity 9,000 -53.5%
Value US$1,061,460
2.1
WILLIAM WADDILL Director Non-Executive Director
Transaction date
Proposed sale
Price
115.03
Quantity 9,000
Value US$1,035,270
2.1
Waddill William D. Non-Executive Director
Transaction date
Sale
Price
107.68
Quantity 9,000 -53.5%
Value US$969,120
2.1
Waddill William D. Non-Executive Director
Transaction date
Sale
Price
107.68
Quantity 9,000 -53.5%
Value US$969,120
2.1
Waddill William D. Non-Executive Director
Transaction date
Sale
Price
107.68
Quantity 9,000 -53.5%
Value US$969,120
2.1
WILLIAM WADDILL Director Non-Executive Director
Transaction date
Proposed sale
Price
105.87
Quantity 9,000
Value US$952,830
2.1
Waddill William D. Non-Executive Director
Transaction date
Sale
Price
99.64
Quantity 9,000 -53.5%
Value US$896,760
2.1
WILLIAM WADDILL Director Non-Executive Director
Transaction date
Proposed sale
Price
100.41
Quantity 9,000
Value US$903,690
2.4
PATEL DINESH V PH D President and CEO Executive Director
Transaction date
Sale
Price
100.12
Quantity 75,000 -12.5%
Value US$7,509,000
2.4
Dinesh Patel CEO
Transaction date
Proposed sale
Price
103.50
Quantity 75,000
Value US$7,762,500
2.3
Giraudo Bryan Non-Executive Director
Transaction date
Sale
Price
100.00
Quantity 5,130 -28.8%
Value US$513,000
2.3
Giraudo Bryan Non-Executive Director
Transaction date
Sale
Price
100.00
Quantity 6,000 -100.0%
Value US$600,000
2.3
BRYAN M & COURTNEY L GIRAUDO RT Director Non-Executive Director
Transaction date
Proposed sale
Price
100.00
Quantity 11,130
Value US$1,113,000
2.3
Giraudo Bryan Non-Executive Director
Transaction date
Sale
Price
100.07
Quantity 12,000 -66.7%
Value US$1,200,840
2.3
Giraudo Bryan Non-Executive Director
Transaction date
Sale
Price
100.14
Quantity 36,000 -56.4%
Value US$3,605,040
2.3
BRYAN GIRAUDO Director Non-Executive Director
Transaction date
Proposed sale
Price
100.14
Quantity 36,000
Value US$3,604,968
2.3
BRYAN M & COURTNEY L GIRAUDO RT Director Non-Executive Director
Transaction date
Proposed sale
Price
100.07
Quantity 12,000
Value US$1,200,874
2.7
Ali Asif Chief Financial Officer Officer
Transaction date
Sale
Price
105.47
Quantity 1,750 -2.9%
Value US$184,572
2.7
Asif Ali Officer Officer
Transaction date
Proposed sale
Price
105.47
Quantity 1,750
Value US$184,572
2.7
Ali Asif Chief Financial Officer Officer
Transaction date
Sale
Price
104.24
Quantity 24,765 -29.0%
Value US$2,581,504
2.9
MOLINA ARTURO MD Chief Medical Officer Officer
Transaction date
Sale
Price
104.79
Quantity 15,000 -15.1%
Value US$1,571,850
2.7
SELICK HAROLD E Non-Executive Director
Transaction date
Sale
Price
105.00
Quantity 24,000 -28.3%
Value US$2,520,000
2.9
ARTURO MOLINA Officer Officer
Transaction date
Proposed sale
Price
104.79
Quantity 15,000
Value US$1,571,919
2.7
ASIF ALI Officer Officer
Transaction date
Proposed sale
Price
104.24
Quantity 24,765
Value US$2,581,546
2.7
HAROLD SELICK Director Non-Executive Director
Transaction date
Proposed sale
Price
105.00
Quantity 24,000
Value US$2,520,000
2.4
PATEL DINESH V PH D President and CEO Executive Director
Transaction date
Sale
Price
101.00
Quantity 54,641 -9.4%
Value US$5,518,741
2.4
PATEL DINESH V PH D President and CEO Executive Director
Transaction date
Sale
Price
101.00
Quantity 59 -0.0%
Value US$5,959
2.4
Dinesh Patel CEO
Transaction date
Proposed sale
Price
98.54
Quantity 54,700
Value US$5,390,138
0.6
Williams Lewis T Non-Executive Director
Transaction date
Sale
Price
82.42
Quantity 18,000 -69.7%
Value US$1,483,560
0.6
LEWIS T WILLIAMS Director Non-Executive Director
Transaction date
Proposed sale
Price
82.42
Quantity 18,000
Value US$1,483,495
2.1
Waddill William D. Non-Executive Director
Transaction date
Sale
Price
83.68
Quantity 20,000 -71.9%
Value US$1,673,600
2.1
WILLIAM D WADDILL Director Non-Executive Director
Transaction date
Proposed sale
Price
83.68
Quantity 20,000
Value US$1,673,672
2.7
ASIF ALI Officer Officer
Transaction date
Proposed sale
Price
83.14
Quantity 46,203
Value US$3,841,128
2.9
ARTURO MOLINA Officer Officer
Transaction date
Proposed sale
Price
82.00
Quantity 5,000
Value US$410,000
2.4
PATEL DINESH V PH D President and CEO Executive Director
Transaction date
Sale
Price
83.19
Quantity 4,068 -0.7%
Value US$338,417
2.9
MOLINA ARTURO MD Chief Medical Officer Officer
Transaction date
Sale
Price
82.00
Quantity 5,000 -5.6%
Value US$410,000
2.7
Ali Asif Chief Financial Officer Officer
Transaction date
Sale
Price
83.14
Quantity 18,203 -23.2%
Value US$1,513,397
2.7
Ali Asif Chief Financial Officer Officer
Transaction date
Sale
Price
83.13
Quantity 28,000 -26.3%
Value US$2,327,640
2.4
PATEL DINESH V PH D President and CEO Executive Director
Transaction date
Sale
Price
84.05
Quantity 14,205 -2.4%
Value US$1,193,930
2.4
PATEL DINESH V PH D President and CEO Executive Director
Transaction date
Sale
Price
84.00
Quantity 10,685 -1.8%
Value US$897,540
2.9
MOLINA ARTURO MD Chief Medical Officer Officer
Transaction date
Sale
Price
82.28
Quantity 5,000 -5.6%
Value US$411,400
2.9
ARTURO MOLINA Officer Officer
Transaction date
Proposed sale
Price
82.28
Quantity 5,000
Value US$411,396
2.4
PATEL DINESH V PH D President and CEO Executive Director
Transaction date
Sale
Price
84.59
Quantity 19,315 -3.3%
Value US$1,633,856
2.9
MOLINA ARTURO MD Chief Medical Officer Officer
Transaction date
Sale
Price
82.42
Quantity 13,151 -13.5%
Value US$1,083,905
2.4
Dinesh Patel CEO
Transaction date
Proposed sale
Price
84.62
Quantity 108,273
Value US$9,162,061
2.9
ARTURO MOLINA Officer Officer
Transaction date
Proposed sale
Price
83.42
Quantity 13,151
Value US$1,097,116
2.9
ARTURO MOLINA MD Officer Officer
Transaction date
Proposed sale
Price
82.48
Quantity 9,514
Value US$784,715
2.4
DINESH V PATEL PH D Officer, Director Executive Director
Transaction date
Proposed sale
Price
82.48
Quantity 34,438
Value US$2,840,446
2.7
Asif Ali Officer Officer
Transaction date
Proposed sale
Price
82.48
Quantity 8,588
Value US$708,338
2.9
MOLINA ARTURO MD Chief Medical Officer Officer
Transaction date
Sale
Price
82.48
Quantity 9,514 -8.9%
Value US$784,715
2.4
PATEL DINESH V PH D President and CEO Executive Director
Transaction date
Sale
Price
82.48
Quantity 34,438 -5.6%
Value US$2,840,446
2.7
Ali Asif Chief Financial Officer Officer
Transaction date
Sale
Price
82.48
Quantity 8,588 -9.9%
Value US$708,338
2.9
MOLINA ARTURO MD Chief Medical Officer Officer
Transaction date
Sale
Price
84.77
Quantity 2,712 -3.2%
Value US$229,896
2.1
Waddill William D. Non-Executive Director
Transaction date
Planned sale
Price
87.81
Quantity 8,000 -60.9%
Value US$702,480
2.1
Waddill William D. Non-Executive Director
Transaction date
Planned sale
Price
69.25
Quantity 4,000 -23.4%
Value US$277,000
2.1
WILLIAM WADDILL Director Non-Executive Director
Transaction date
Proposed sale
Price
67.04
Quantity 12,000
Value US$804,480
2.1
Waddill William D. Non-Executive Director
Transaction date
Planned sale
Price
64.25
Quantity 4,000 -43.8%
Value US$257,000
2.1
WILLIAM WADDILL Director Non-Executive Director
Transaction date
Proposed sale
Price
62.20
Quantity 4,000
Value US$248,800
2.1
Waddill William D. Non-Executive Director
Transaction date
Planned sale
Price
59.25
Quantity 4,000 -30.5%
Value US$237,000
2.1
WILLIAM WADDILL Director Non-Executive Director
Transaction date
Proposed sale
Price
56.99
Quantity 4,000
Value US$227,960
2.4
PATEL DINESH V PH D President and CEO Executive Director
Transaction date
Sale
Price
54.78
Quantity 10,415 -2.0%
Value US$570,534
2.4
PATEL DINESH V PH D President and CEO Executive Director
Transaction date
Sale
Price
54.79
Quantity 17,520 -3.2%
Value US$959,921
2.4
PATEL DINESH V PH D President and CEO Executive Director
Transaction date
Sale
Price
55.05
Quantity 22,065 -3.9%
Value US$1,214,678
2.4
Dinesh Patel CEO
Transaction date
Proposed sale
Price
55.22
Quantity 50,000
Value US$2,761,000
2.4
PATEL DINESH V PH D President and CEO Executive Director
Transaction date
Sale
Price
54.86
Quantity 12,859 -2.2%
Value US$705,445
2.9
MOLINA ARTURO MD Chief Medical Officer Officer
Transaction date
Sale
Price
57.03
Quantity 10,000 -10.7%
Value US$570,300
2.9
ARTURO MOLINA Officer Officer
Transaction date
Proposed sale
Price
57.03
Quantity 10,000
Value US$570,269
2.9
MOLINA ARTURO MD Chief Medical Officer Officer
Transaction date
Sale
Price
55.51
Quantity 10,000 -10.7%
Value US$555,100
2.9
ARTURO MOLINA Officer Officer
Transaction date
Proposed sale
Price
55.51
Quantity 10,000
Value US$555,077
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2026-09-10 2026-09-10 S Sale

President and CEO

Executive Director
34,410 -41.5%
104.74
US$2,070,241
34,410 -41.5% 104.74 US$2,070,241
2026-09-10 2026-09-09 S Sale

President and CEO

Executive Director
39,963 -3.3%
332.06
US$2,305,480
39,963 -3.3% 332.06 US$2,305,480
2026-09-10 2026-09-08 S Sale

President and CEO

Executive Director
92,506 -27.0%
420.97
US$1,136,455
92,506 -27.0% 420.97 US$1,136,455
2026-08-12 2026-08-11 S Sale

President and CEO

Executive Director
34,239 -6.1%
148.52
US$5,085,176
34,239 -6.1% 148.52 US$5,085,176
2026-08-12 2026-08-10 S Sale

President and CEO

Executive Director
65,761 -11.2%
149.11
US$9,805,623
65,761 -11.2% 149.11 US$9,805,623
2026-08-10 2026-08-10 PrS Proposed sale

CEO

225,000
149.26
US$33,583,500
225,000 149.26 US$33,583,500
2026-06-25 2026-06-23 S Sale Non-Executive Director
9,000 -53.5%
117.94
US$1,061,460
9,000 -53.5% 117.94 US$1,061,460
2026-06-23 2026-06-23 PrS Proposed sale

Director

Non-Executive Director
9,000
115.03
US$1,035,270
9,000 115.03 US$1,035,270
2026-06-11 2026-06-10 S Sale Non-Executive Director
9,000 -53.5%
107.68
US$969,120
9,000 -53.5% 107.68 US$969,120
2026-06-11 2026-06-10 S Sale Non-Executive Director
9,000 -53.5%
107.68
US$969,120
9,000 -53.5% 107.68 US$969,120
2026-06-11 2026-06-10 S Sale Non-Executive Director
9,000 -53.5%
107.68
US$969,120
9,000 -53.5% 107.68 US$969,120
2026-06-10 2026-06-10 PrS Proposed sale

Director

Non-Executive Director
9,000
105.87
US$952,830
9,000 105.87 US$952,830
2026-06-01 2026-05-29 S Sale Non-Executive Director
9,000 -53.5%
99.64
US$896,760
9,000 -53.5% 99.64 US$896,760
2026-05-29 2026-05-29 PrS Proposed sale

Director

Non-Executive Director
9,000
100.41
US$903,690
9,000 100.41 US$903,690
2026-05-12 2026-05-12 S Sale

President and CEO

Executive Director
75,000 -12.5%
100.12
US$7,509,000
75,000 -12.5% 100.12 US$7,509,000
2026-05-12 2026-05-12 PrS Proposed sale

CEO

75,000
103.50
US$7,762,500
75,000 103.50 US$7,762,500
2026-05-11 2026-05-08 S Sale Non-Executive Director
5,130 -28.8%
100.00
US$513,000
5,130 -28.8% 100.00 US$513,000
2026-05-11 2026-05-08 S Sale Non-Executive Director
6,000 -100.0%
100.00
US$600,000
6,000 -100.0% 100.00 US$600,000
2026-05-08 2026-05-08 PrS Proposed sale

Director

Non-Executive Director
11,130
100.00
US$1,113,000
11,130 100.00 US$1,113,000
2026-05-11 2026-05-07 S Sale Non-Executive Director
12,000 -66.7%
100.07
US$1,200,840
12,000 -66.7% 100.07 US$1,200,840
2026-05-11 2026-05-07 S Sale Non-Executive Director
36,000 -56.4%
100.14
US$3,605,040
36,000 -56.4% 100.14 US$3,605,040
2026-05-07 2026-05-07 PrS Proposed sale

Director

Non-Executive Director
36,000
100.14
US$3,604,968
36,000 100.14 US$3,604,968
2026-05-07 2026-05-07 PrS Proposed sale

Director

Non-Executive Director
12,000
100.07
US$1,200,874
12,000 100.07 US$1,200,874
2026-04-21 2026-04-20 S Sale

Chief Financial Officer

Officer
1,750 -2.9%
105.47
US$184,572
1,750 -2.9% 105.47 US$184,572
2026-04-21 2026-04-20 PrS Proposed sale

Officer

Officer
1,750
105.47
US$184,572
1,750 105.47 US$184,572
2026-03-27 2026-03-26 S Sale

Chief Financial Officer

Officer
24,765 -29.0%
104.24
US$2,581,504
24,765 -29.0% 104.24 US$2,581,504
2026-03-27 2026-03-26 S Sale

Chief Medical Officer

Officer
15,000 -15.1%
104.79
US$1,571,850
15,000 -15.1% 104.79 US$1,571,850
2026-03-27 2026-03-26 S Sale Non-Executive Director
24,000 -28.3%
105.00
US$2,520,000
24,000 -28.3% 105.00 US$2,520,000
2026-03-26 2026-03-26 PrS Proposed sale

Officer

Officer
15,000
104.79
US$1,571,919
15,000 104.79 US$1,571,919
2026-03-26 2026-03-26 PrS Proposed sale

Officer

Officer
24,765
104.24
US$2,581,546
24,765 104.24 US$2,581,546
2026-03-26 2026-03-26 PrS Proposed sale

Director

Non-Executive Director
24,000
105.00
US$2,520,000
24,000 105.00 US$2,520,000
2026-03-25 2026-03-25 S Sale

President and CEO

Executive Director
54,641 -9.4%
101.00
US$5,518,741
54,641 -9.4% 101.00 US$5,518,741
2026-03-25 2026-03-24 S Sale

President and CEO

Executive Director
59 -0.0%
101.00
US$5,959
59 -0.0% 101.00 US$5,959
2026-03-24 2026-03-24 PrS Proposed sale

CEO

54,700
98.54
US$5,390,138
54,700 98.54 US$5,390,138
2026-02-18 2026-02-17 S Sale Non-Executive Director
18,000 -69.7%
82.42
US$1,483,560
18,000 -69.7% 82.42 US$1,483,560
2026-02-17 2026-02-17 PrS Proposed sale

Director

Non-Executive Director
18,000
82.42
US$1,483,495
18,000 82.42 US$1,483,495
2026-02-06 2026-02-06 S Sale Non-Executive Director
20,000 -71.9%
83.68
US$1,673,600
20,000 -71.9% 83.68 US$1,673,600
2026-02-06 2026-02-06 PrS Proposed sale

Director

Non-Executive Director
20,000
83.68
US$1,673,672
20,000 83.68 US$1,673,672
2026-01-27 2026-01-27 PrS Proposed sale

Officer

Officer
46,203
83.14
US$3,841,128
46,203 83.14 US$3,841,128
2026-01-27 2026-01-27 PrS Proposed sale

Officer

Officer
5,000
82.00
US$410,000
5,000 82.00 US$410,000
2026-01-27 2026-01-27 S Sale

President and CEO

Executive Director
4,068 -0.7%
83.19
US$338,417
4,068 -0.7% 83.19 US$338,417
2026-01-27 2026-01-27 S Sale

Chief Medical Officer

Officer
5,000 -5.6%
82.00
US$410,000
5,000 -5.6% 82.00 US$410,000
2026-01-27 2026-01-27 S Sale

Chief Financial Officer

Officer
18,203 -23.2%
83.14
US$1,513,397
18,203 -23.2% 83.14 US$1,513,397
2026-01-27 2026-01-27 S Sale

Chief Financial Officer

Officer
28,000 -26.3%
83.13
US$2,327,640
28,000 -26.3% 83.13 US$2,327,640
2026-01-27 2026-01-26 S Sale

President and CEO

Executive Director
14,205 -2.4%
84.05
US$1,193,930
14,205 -2.4% 84.05 US$1,193,930
2026-01-27 2026-01-26 S Sale

President and CEO

Executive Director
10,685 -1.8%
84.00
US$897,540
10,685 -1.8% 84.00 US$897,540
2026-01-27 2026-01-26 S Sale

Chief Medical Officer

Officer
5,000 -5.6%
82.28
US$411,400
5,000 -5.6% 82.28 US$411,400
2026-01-26 2026-01-26 PrS Proposed sale

Officer

Officer
5,000
82.28
US$411,396
5,000 82.28 US$411,396
2026-01-27 2026-01-23 S Sale

President and CEO

Executive Director
19,315 -3.3%
84.59
US$1,633,856
19,315 -3.3% 84.59 US$1,633,856
2026-01-27 2026-01-23 S Sale

Chief Medical Officer

Officer
13,151 -13.5%
82.42
US$1,083,905
13,151 -13.5% 82.42 US$1,083,905
2026-01-23 2026-01-23 PrS Proposed sale

CEO

108,273
84.62
US$9,162,061
108,273 84.62 US$9,162,061
2026-01-23 2026-01-23 PrS Proposed sale

Officer

Officer
13,151
83.42
US$1,097,116
13,151 83.42 US$1,097,116
2026-01-21 2026-01-20 PrS Proposed sale

Officer

Officer
9,514
82.48
US$784,715
9,514 82.48 US$784,715
2026-01-21 2026-01-20 PrS Proposed sale

Officer, Director

Executive Director
34,438
82.48
US$2,840,446
34,438 82.48 US$2,840,446
2026-01-21 2026-01-20 PrS Proposed sale

Officer

Officer
8,588
82.48
US$708,338
8,588 82.48 US$708,338
2026-01-21 2026-01-20 S Sale

Chief Medical Officer

Officer
9,514 -8.9%
82.48
US$784,715
9,514 -8.9% 82.48 US$784,715
2026-01-21 2026-01-20 S Sale

President and CEO

Executive Director
34,438 -5.6%
82.48
US$2,840,446
34,438 -5.6% 82.48 US$2,840,446
2026-01-21 2026-01-20 S Sale

Chief Financial Officer

Officer
8,588 -9.9%
82.48
US$708,338
8,588 -9.9% 82.48 US$708,338
2025-11-19 2025-11-17 S Sale

Chief Medical Officer

Officer
2,712 -3.2%
84.77
US$229,896
2,712 -3.2% 84.77 US$229,896
2025-10-14 2025-10-10 PlS Planned sale Non-Executive Director
8,000 -60.9%
87.81
US$702,480
8,000 -60.9% 87.81 US$702,480
2025-10-14 2025-10-10 PlS Planned sale Non-Executive Director
4,000 -23.4%
69.25
US$277,000
4,000 -23.4% 69.25 US$277,000
2025-10-10 2025-10-10 PrS Proposed sale

Director

Non-Executive Director
12,000
67.04
US$804,480
12,000 67.04 US$804,480
2025-09-24 2025-09-22 PlS Planned sale Non-Executive Director
4,000 -43.8%
64.25
US$257,000
4,000 -43.8% 64.25 US$257,000
2025-09-22 2025-09-22 PrS Proposed sale

Director

Non-Executive Director
4,000
62.20
US$248,800
4,000 62.20 US$248,800
2025-08-29 2025-08-27 PlS Planned sale Non-Executive Director
4,000 -30.5%
59.25
US$237,000
4,000 -30.5% 59.25 US$237,000
2025-08-27 2025-08-27 PrS Proposed sale

Director

Non-Executive Director
4,000
56.99
US$227,960
4,000 56.99 US$227,960
2025-07-28 2025-07-25 S Sale

President and CEO

Executive Director
10,415 -2.0%
54.78
US$570,534
10,415 -2.0% 54.78 US$570,534
2025-07-23 2025-07-23 S Sale

President and CEO

Executive Director
17,520 -3.2%
54.79
US$959,921
17,520 -3.2% 54.79 US$959,921
2025-07-23 2025-07-22 S Sale

President and CEO

Executive Director
22,065 -3.9%
55.05
US$1,214,678
22,065 -3.9% 55.05 US$1,214,678
2025-07-22 2025-07-22 PrS Proposed sale

CEO

50,000
55.22
US$2,761,000
50,000 55.22 US$2,761,000
2025-07-23 2025-07-21 S Sale

President and CEO

Executive Director
12,859 -2.2%
54.86
US$705,445
12,859 -2.2% 54.86 US$705,445
2025-06-11 2025-06-10 S Sale

Chief Medical Officer

Officer
10,000 -10.7%
57.03
US$570,300
10,000 -10.7% 57.03 US$570,300
2025-06-10 2025-06-10 PrS Proposed sale

Officer

Officer
10,000
57.03
US$570,269
10,000 57.03 US$570,269
2025-06-11 2025-06-09 S Sale

Chief Medical Officer

Officer
10,000 -10.7%
55.51
US$555,100
10,000 -10.7% 55.51 US$555,100
2025-06-09 2025-06-09 PrS Proposed sale

Officer

Officer
10,000
55.51
US$555,077
10,000 55.51 US$555,077